Frankfurt - Delayed Quote EUR
Theralase Technologies Inc. (TTX.F)
0.1090
+0.0020
+(1.87%)
At close: 8:04:38 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 19.67M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Dumoulin-White (Roger John) 10% Security Holder of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 8,320 | Mar 11, 2025 |
| Hachey (Kristina Maria) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 8,320 | Mar 11, 2025 |
| Lbiati (Kaouthar) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 6,933 | Mar 11, 2025 |
| Mandel (Arkady) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 8,320 | Mar 11, 2025 |
| Perraton, Matthew Thomas Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.21 per share. | Direct | 8,320 | Mar 11, 2025 |